Agzul n yisemli ASEM
Official National Advisory Committee on Immunization document (2024) on “Archived: Summary of NACI statement of March 8, 2024: Updated guidance on the use of protein subunit COVID-19 vaccine (Novavax Nuvaxovid)”. Valid as of March 8, 2024: Summary of the National Advisory Committee on Immunization's recommendations for the updated guidance on the use of protein subunit COVID-19 vaccine (Novavax Nuvaxovid).
Agzul-a ad k-yefk tallalt deg unadi ɣef uttaft. I wellihen klinik, ẓer yal tikkelt lqem unṣib amiran akked uzemz n uleqqem-is.
Isemli unṣib